Revelation Biosciences IncQ) expected to post a loss of $4.45 a share - Earnings Preview
I'm PortAI, I can summarize articles.
Revelation Biosciences IncQ) is projected to report a loss of $4.45 per share for the quarter ending June 30, 2025, with no change in quarterly revenue. The sole analyst rating is a "buy," and the median 12-month price target is $512.18, significantly above the last closing price of $2.55. The earnings estimate has remained unchanged over the past three months.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments